Management strategies for poor peripheral blood stem cell mobilization
- 30 June 2008
- journal article
- review article
- Published by Elsevier BV in Transfusion and Apheresis Science
- Vol. 38 (3), 229-236
- https://doi.org/10.1016/j.transci.2008.04.002
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Factors influencing the collection of peripheral blood stem cells in patients with acute myeloblastic leukemia and non-myeloid malignanciesLeukemia Research, 2003
- Transplantation of Bone Marrow as Compared with Peripheral-Blood Cells from HLA-Identical Relatives in Patients with Hematologic CancersNew England Journal of Medicine, 2001
- Favorable treatment outcome in non-Hodgkin's lymphoma patients with "poor" mobilization of peripheral blood progenitor cellsTransplantation and Cellular Therapy, 2000
- Granulocyte colony-stimulating factor (G-CSF) dose-dependent efficacy in peripheral blood stem cell mobilization in patients who had failed initial mobilization with chemotherapy and G-CSFBone Marrow Transplantation, 1998
- Hematopoietic rescue after high-dose chemotherapy using autologous peripheral-blood progenitor cells or bone marrow: a randomized comparison.Journal of Clinical Oncology, 1995
- Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphomaBlood, 1994
- Economic evaluation of peripheral blood stem cell transplantation for lymphomaThe Lancet, 1992
- Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapyThe Lancet, 1992
- Peripheral blood stem cell collection and use in Hodgkin's disease. Comparison with marrow in autologous transplantationTransfusion, 1989
- Autologous transplantation of blood-derived hemopoietic stem cells after myeloablative therapy in a patient with Burkitt's lymphomaBlood, 1986